Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing and array-based technologies, today announced a collaboration with Broad Clinical Labs to rapidly streamline and scale ...
Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that ...
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of | Roche said ...
“The small RNA sequencing was going to take a lot of customization ... Download the new Introduction to Next-Generation Sequencing ebook from Illumina to learn more. You might also be interested in ...
Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about ...
RBC Capital reiterated an Outperform rating and $247 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...
Now, although traditional RNA sequencing has played an instrumental ... the BD Rhapsody system, and Illumina sequencing technologies. Next, the researchers discuss the multiple steps involved ...
Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.
to the native DNA and RNA, and then we provide the proteome ... you’re seeing several newer challengers taken in sequencing? We’ve seen Illumina change its CEO and refocus somewhat and shift ...
In the first presentation of this GEN webinar, our expert speaker Devansh Agarwal will present results from a study and how the scientists generated RGC-like induced neurons in under a week by ...
Illumina, Inc. offers sequencing- and array-based solutions ... specific genes, and RNA or other genomic regions of interest.